Search Browse Earnings

Kiromic Biopharma, Inc. — SlamSEC

Kiromic Biopharma, Inc.

Biological Products, (No Diagnostic Substances)·HOUSTON, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2024

Adj. EBITDA

-$17.7M

FY 2024

Net Income

-$20.9M

FY 2024

EPS (Diluted)

-$64.42

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$3.2M

FY 2024

Total Debt

$557,200

FY 2023

Net Cash

$2.6M

FY 2023

Enterprise Value

—

Debt / EBITDA

0.1x

FY 2024

EV / EBITDA

—

Employees

—

CEO

Bersani Pietro

CFO

Hungerford Brian